Research Achievements

November 13, 2017  PRESS RELEASE

Deadly Combination in Neurodegenerative Diseases Revealed

Japanese researchers develop new mouse model that captures pathology of sporadic neurological diseases 

press released on November 13, 2017

 

Figure: Degenerating interneurons in frontotemporal lobar degeneration (FTLD) mice

(a) Poly-ubiquitin positive protein aggregates (arrows) in the hippocampus of aged FTLD mice (TDP-43 transgenic mice). (b) Immunofluorescence staining show these aggregates contain p62 and parvalbumin, a marker of interneurons (arrows). (c) Staining by parvalbumin antibody show intact (arrowheads) and degenerating interneurons (arrows) in the hippocampus of aged FTLD mice. © Hitomi Tsuiji and Koji Yamanaka

 

Nagoya, Japan - Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and death of nerve cells, which leads to problems with movement or mental functioning. Examples include Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). ALS is characterized by degeneration of motor neurons, while FTD is characterized by progressive neuronal loss mostly in the frontal and/or temporal lobes of the brain.

 

Neurodegenerative diseases are increasingly being realized to have common cellular and molecular mechanisms including protein misfolding and aggregation. In nearly half of all FTD cases and in 97% of the ALS cases, there is an accumulation of the protein TDP-43 in the affected neurons, the basic working units of the nervous system.

 

In a non-disease state, TDP-43 is an important protein involved in various aspects of the metabolism of RNA, a molecule essential in various biological roles in the regulation and expression of genes. In a disease state, several mutations in TDP-43 have been identified as a cause of some hereditary and sporadic ALS and FTD cases. While this underscores the critical role of TDP-43 in the development of these conditions, the specific effect of aging on TDP-43 has not been investigated. This prompted a team of scientists centered in Nagoya, Japan, to delve deep into the subject. Their findings were recently published in Scientific Reports.

 

For their investigation, the researchers first developed a disease model of transgenic mice expressing elevated levels of TDP-43 to capture the pathology of sporadic ALS/FTD. They then performed serial behavioral tests on the mice, including Y-maze test (to assess working memory), rotarod test (motor function and learning), and contextual and cued fear condition test (fear learning and memory).

 

"In transgenic mice expressing unusually high levels of TDP-43 we observed memory and motor deficits," study corresponding author Koji Yamanaka says. "We also noticed an accumulation of debris of interneurons - the cells that serve as a connection between sensory and motor pathways for reflexes - in the hippocampus, which is responsible for memory storage."

 

Notably, the abundance of aggregates drastically increased with age and with the overexpression of TDP-43. Gene analyses of the hippocampus and other brain areas revealed dysregulation in the genes linked to manifestation of damaging reactive oxygen species and neuronal function.

 

"The degeneration of interneurons as seen in our mouse model could be the very early age-accelerated changes observed in the diseases," Yamanaka says. "Moreover, it has been reported that inhibitory interneuron deficits link altered network activity and cognitive dysfunction in models of Alzheimer's disease. Therefore, this particular mouse model may be useful for studying neurological diseases accelerated by aging."

 

*****

The article, "TDP-43 accelerates age-dependent degeneration of interneurons" was published in Scientific Reports at DOI: 10.1038/s41598-017-14966-w

 

*****

Authors: Hitomi Tsuiji1,2, Ikuyo Inoue2, Mari Takeuchi1, Asako Furuya2, Yuko Yamakage1, Seiji Watanabe2,3, Masato Koike 4, Mitsuharu Hattori1 & Koji Yamanaka2,3

1 Department of Biomedical Science, Graduate School of Pharmaceutical Sciences, Nagoya City University

2 Laboratory for Motor Neuron Disease, RIKEN Brain Science Institute

3 Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University

4 Department of Cell Biology and Neuroscience, Juntendo University Graduate School of Medicine

 

*****

Related Links:

Research Institute of Environmental Medicine(RIEM), Nagoya University

 

Koji Yamanaka Lab., Department of Neuroscience and Pathobiology, RIEM, Nagoya University

 

Graduate School of Pharmaceutical Sciences, Nagoya City University

 

"Collapse of mitochondria-associated membrane in ALS", press release, November 8, 2017

 

*****

Media Coverage:

EurekAlert!

AlphaGalileo

Asia Research News

Science Daily

Neuroscience News

Medical Xpress

The Medical News

Spasique

Health Canal

Scienmag

*****

Funding: This work was supported by Grant-in-Aid nos. 25430055 (to H.T.) and 26293208 (to K.Y.) from the Ministry of Education, Culture, and Sports, Science, and Technology (MEXT) of Japan, Grant-in-Aid for Research on Rare and Intractable Diseases, the Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis from the Japan Agency for Medical Research and Development (AMED), JST CREST, and the Japan ALS association (JALSA) (to K.Y.), and Grantin-Aid for Research from Nagoya City University (to H.T.). This work was supported by JSPS KAKENHI Grant Number JP16H06280, Grant-in-Aid for Scientific Research on Innovative Areas- Resource and technical support platforms for promoting research 'Advanced Bioimaging Support'.

 

 

 

 

Archive List
2017
2016
2015
2014
2013